Şunu aradınız:: kardiovaskularnih (Hırvatça - İngilizce)

kardiovaskularnih stanja
cardiovascular conditions.

odabranih kardiovaskularnih ishoda.
and the risk of selected cardiovascular endpoints.

ocjenjivanje kardiovaskularnih (kv) događaja
evaluation of cardiovascular (cv) events

lijekovi za lijeČenje kardiovaskularnih bolesti
cardiovascular agents

i šestina stope kardiovaskularnih bolesti .
and one sixth the rate of cardiovascular disease .

mace prijavljeni u ispitivanju kardiovaskularnih ishoda
mace reported in cardiovascular outcomes study

atosiban nije imao kardiovaskularnih učinaka u životinja.
in animals atosiban did not exhibit cardiovascular effects.

provedena je metaanaliza kardiovaskularnih događaja u kliničkom programu.
a meta-analysis of cardiovascular events in the clinical program was performed.

nemojte primjenjivati ako psi boluju od teških kardiovaskularnih bolesti.
do not use in dogs with severe cardiovascular disorders.

kardiovaskularnih stanja (npr. stezanje krvnih žila u plućima)
cardiovascular conditions (e.g. constriction of blood vessels in the lung).

pojavu velikih štetnih kardiovaskularnih događaja (engl. major adverse
release (er) /bupropion er on the occurrence of major adverse cardiovascular

u slučaju teških kardiovaskularnih bolesti, potreban je poseban oprez.
in case of severe cardiovascular disease, care should be taken.

za prevenciju kardiovaskularnih problema, preporučena doza iznosi 80 mg jedanput na dan.
for the prevention of cardiovascular problems, the recommended dose is 80 mg once a day.

glavni kriterij djelotvornosti bio je skup kardiovaskularnih smrtnosti ili nefatalni infarkt miokarda.
the main efficacy criterion was the composite of cardiovascular death or non-fatal mi.

dapagliflozin: provedena je meta-analiza kardiovaskularnih događaja u kliničkom programu.
dapagliflozin: a meta-analysis of cardiovascular events in the clinical program was performed.

ljudi bi češće patili od kardiovaskularnih bolesti i tropskih infekcija, kao što je malarija.
people would more frequently suffer from cardiovascular diseases and tropical infections, such as malaria.

hipotenzija se može pojaviti češće u bolesnika koji primaju lijek kinzalmono radi prevencije kardiovaskularnih problema.
hypotension may be more common in patients receiving kinzalmono to prevent cardiovascular problems.

istraživači su ispitivali modele kardiovaskularnih čimbenika rizika prikupljajući podatke od približno 1.000 pacijenata.
the researchers investigated patterns of cardiovascular risk factors by collecting data from almost 1,000 patients.

bolesnicima treba savjetovati da odmah potraže liječničku pomoć ako primijete akutne znakove ili simptome kardiovaskularnih događaja.
patients should be advised to seek immediate medical attention if they experience acute signs or symptoms of cardiovascular events.

apsolutni rizik od kardiovaskularnih malformacija povećan je s manje od 1% na do oko 1,5%.
the absolute risk for cardiovascular malformation was increased from less than 1%, up to approximately 1.5%.